imatinib mesylate has been researched along with Glomerulonephritis, Minimal Change in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Luo, Y; Wang, G; Zhuo, N | 1 |
| Backlund, B; Cianciolo, RE; Clubb, FJ; Cook, AK; Lees, GE | 1 |
2 other study(ies) available for imatinib mesylate and Glomerulonephritis, Minimal Change
| Article | Year |
|---|---|
Imatinib-induced podocytopathies in a patient with gastrointestinal stromal tumor.
Topics: Antineoplastic Agents; Gastrointestinal Stromal Tumors; Glomerulosclerosis, Focal Segmental; Humans; Imatinib Mesylate; Kidney Function Tests; Male; Middle Aged; Nephrosis, Lipoid | 2021 |
Minimal change glomerulopathy in a cat.
Topics: Animals; Benzamides; Cat Diseases; Cats; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukocyte Count; Male; Nephrosis, Lipoid; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2011 |